Neurotrack
Company

Last deal

$10.M

Amount

Undisclosed

Stage

01.11.2022

Date

9

all rounds

$60.4M

Total amount

General

About Company
Neurotrack develops digital cognitive health solutions to reduce the risk of Alzheimer's and related dementias.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2012

Number of employees

Company Type

For Profit

Last funding type

Undisclosed

IPO status

Private

Description

The company's platform offers cognitive health programs to assess, preserve and strengthen memory health, enabling individuals to manage their brain health and reduce the risk of cognitive decline in the future. Its rapid digital cognitive screening can identify patients with cognitive impairment in just 3 minutes, making it easy to administer and score, and it fits easily within a typical primary care annual wellness visit workflow. Neurotrack has published 23 peer-reviewed papers and has enabled more than 170,000 cognitive assessments on its platform, and has raised $57 million in funding to support and accelerate its go-to-market push with major health systems and providers.
Contacts

Phone number

Social url